List view / Grid view
Dana-Farber Cancer Institute
Having identified the histone demethylase KDM5A as a multiple myeloma target, researchers developed a KDM5 inhibitor to treat the cancer.
Researchers investigating telomere dieases such as dyskeratosis congenita have found lead compounds that reverse cellular ageing in mouse models of the condition.
Researchers have screened thousands of existing drug molecules against cancer cell lines to discover almost 50 compounds that combat the condition.
Researchers have carried out the largest genomic analysis of patients with SMM to explain the biology of the disease and how it unfolds through time...
Genomic analysis has shown a better framework for understanding lymphoma’s many forms and will help to predict individual patient outcomes and guide personalised treatment.
Improved methods validate the use of blood samples for studying patients' cancer genomes
Researchers find key molecule that could lead to new therapies for anaemia and other iron disorders.
8 July 2016 | By Victoria White, Digital Content Producer
A study has found that let-7 plays a central role in curbing neuroblastoma and could focus efforts to find a targeted, nontoxic alternative to chemotherapy...
30 June 2016 | By Victoria White, Digital Content Producer
Scientists identified a natural molecular pathway that enables cells to burn off calories as heat rather than store them as fat...